XML 47 R38.htm IDEA: XBRL DOCUMENT v3.26.1
Net Loss Per Share - Computation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Numerator:            
Net loss $ (10,599) $ (5,534) $ (21,126) $ (19,658) $ (16,133) $ (40,784)
Net loss attributable to noncontrolling interest 19   2   22 12
Net loss attributable to Barinthus Biotherapeutics plc shareholders $ (10,580)   $ (21,124)   $ (16,111) $ (40,772)
Denominator:            
Weighted-average ordinary shares outstanding, basic (in shares) 40,848,893   40,343,521   40,848,893 40,304,584
Weighted-average ordinary shares outstanding, diluted (in shares) 40,848,893   40,343,521   40,848,893 40,304,584
Net loss per share attributable to ordinary shareholders, basic (in usd per share) $ (0.26)   $ (0.52)   $ (0.39) $ (1.01)
Net loss per share attributable to ordinary shareholders, diluted (in usd per share) $ (0.26)   $ (0.52)   $ (0.39) $ (1.01)